Expertise in
41
conditions

Dr. Hakan Demirci

Ophthalmology
Regents Of The Univ. Of Michigan
1000 Wall St, 
Ann Arbor, MI 
Clinical Trials:Currently Recruiting for 1 Trial
Offers Telehealth
Expertise in
41
conditions
Regents Of The Univ. Of Michigan
1000 Wall St, 
Ann Arbor, MI 

Overview

Hakan Demirci is an Ophthalmologist in Ann Arbor, Michigan. Dr. Demirci is highly rated in 41 conditions, according to our data. His top areas of expertise are Melanoma of the Eye, Retinoblastoma, Metastatic Uveal Melanoma, Vitrectomy, and Tissue Biopsy.

His clinical research consists of co-authoring 147 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties

Ophthalmology

Licenses

Ophthalmology in MI

Hospital Affiliations

University Of Michigan Health System

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Alliance Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
McLaren Health
  • HMO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
Priority Health
  • HMO
  • POS
Spectrum Priority Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
University of Michigan Health
  • HMO
  • INSURANCE PLAN
  • MEDICARE MAPD
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 11 Less Insurance Carriers -

Locations

Regents of the Univ. of Michigan
1000 Wall St, Ann Arbor, MI 48105
Other Locations
Regents of the University of Michigan
3621 S State St, Ann Arbor, MI 48108

Additional Areas of Focus

Dr. Demirci has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Neurofibromatosis Type 1 (NF1)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Registry of Subjects With Primary Indeterminate Lesions or Choroidal Melanoma
A Registry of Subjects With Primary Indeterminate Lesions or Choroidal Melanoma
Enrollment Status: Recruiting
Publish Date: December 21, 2023
A Phase 3, Multicenter, Open-Label, Long-Term Extension Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Patients With Crohn's Disease
A Phase 3, Multicenter, Open-Label, Long-Term Extension Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Patients With Crohn's Disease
Enrollment Status: Active_not_recruiting
Publish Date: December 15, 2025
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
A Phase 2 Open-label, Ascending Single and Repeat Dose Escalation Trial of Belzupacap Sarotalocan (AU-011) Via Suprachoroidal Administration in Subjects With Primary Indeterminate Lesions and Small Choroidal Melanoma
A Phase 2 Open-label, Ascending Single and Repeat Dose Escalation Trial of Belzupacap Sarotalocan (AU-011) Via Suprachoroidal Administration in Subjects With Primary Indeterminate Lesions and Small Choroidal Melanoma
Enrollment Status: Completed
Publish Date: March 03, 2025
Intervention Type: Device, Drug
Study Drug: AU-011
Study Phase: Phase 2
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active- Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Crohn's Disease
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active- Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Crohn's Disease
Enrollment Status: Completed
Publish Date: December 27, 2024
Intervention Type: Drug
Study Drugs: Mirikizumab, Ustekinumab
Study Phase: Phase 3
View 3 Less Clinical Trials

147 Total Publications

Infantile myofibromatosis with orbital involvement: a case presentation and review of the literature.
Infantile myofibromatosis with orbital involvement: a case presentation and review of the literature.
Journal: Orbit (Amsterdam, Netherlands)
Published: January 13, 2026
Similar Doctors
Expertise in
29
conditions
Dr. Abigail Fahim
Ophthalmology
Expertise in
29
conditions
Dr. Abigail Fahim
Ophthalmology

Regents Of The Univ. Of Michigan

1000 Wall St, 
Ann Arbor, MI 
 (0.1 miles away)
734-764-4190
Experience:
17+ years
Languages Spoken:
English
See accepted insurances

Abigail Fahim is an Ophthalmologist in Ann Arbor, Michigan. Dr. Fahim has been practicing medicine for over 17 years is highly rated in 29 conditions, according to our data. Her top areas of expertise are X-Linked Retinitis Pigmentosa (XLRP), Retinitis Pigmentosa, Retinopathy Pigmentary Mental Retardation, and Usher Syndrome Type 2A.

Expertise in
30
conditions
Dr. Kanishka Jayasundera
Ophthalmology
Expertise in
30
conditions
Dr. Kanishka Jayasundera
Ophthalmology

Regents Of The Univ. Of Michigan

1000 Wall St, 
Ann Arbor, MI 
 (0.1 miles away)
734-764-4190
Languages Spoken:
English
See accepted insurances

Kanishka Jayasundera is an Ophthalmologist in Ann Arbor, Michigan. Dr. Jayasundera is highly rated in 30 conditions, according to our data. His top areas of expertise are Retinitis Pigmentosa, Late-Onset Retinal Degeneration, Retinopathy Pigmentary Mental Retardation, and Usher Syndrome Type 2A.

Expertise in
43
conditions
Dr. Shahzad Mian
Ophthalmology
Expertise in
43
conditions
Dr. Shahzad Mian
Ophthalmology

Regents Of The Univ. Of Michigan

1000 Wall St, 
Ann Arbor, MI 
 (0.1 miles away)
734-764-4190
Languages Spoken:
English
See accepted insurances

Shahzad Mian is an Ophthalmologist in Ann Arbor, Michigan. Dr. Mian is highly rated in 43 conditions, according to our data. His top areas of expertise are Cataract, Interstitial Keratitis, Fuchs Dystrophy, Corneal Transplant, and Cataract Removal.

Frequently Asked Questions about Dr. Hakan Demirci

How do I make an appointment with Dr. Hakan Demirci?

You can book an appointment with Dr. Hakan Demirci by calling their office at 734-764-4190. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Hakan Demirci a top-rated expert for Melanoma of the Eye?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Hakan Demirci is classified as an Elite expert for Melanoma of the Eye, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Hakan Demirci specialize in?

While Dr. Hakan Demirci is a Ophthalmology, they have specific expertise in Melanoma of the Eye, Retinoblastoma, and Metastatic Uveal Melanoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Ophthalmology.

Does Dr. Hakan Demirci participate in research or clinical trials?

Yes. Dr. Hakan Demirci has published 147 articles and abstracts on conditions like Melanoma of the Eye. You can view a list of Dr. Hakan Demirci's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Hakan Demirci accept my insurance?

Dr. Hakan Demirci accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 734-764-4190 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Demirci's expertise for a condition
ConditionClose
View All 33 Advanced Conditions
View All 59 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile